A
$ Value
$0
Shares
6,378
Price
$0
Filed
May 1
Insider
Name
Nader Francois
Title
—
CIK
0001365343
Roles
Director
Transaction Details
Transaction Date
2025-04-30
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,378
Footnotes
This option will become fully vested and exercisable on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service. | Restricted stock units convert into common stock on a one-for-one basis. | The shares subject to this restricted stock unit award will vest in full on the earlier of April 30, 2026, or Moderna's next Annual Meeting of Shareholders, subject to the recipient's continued service.
Filing Info
Nader Francois's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | TECX | A | $0 |
| 2025-04-30 | MRNA | A | $0 |
| 2025-04-30 | MRNA | A | $0 |
Other Insiders at MRNA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Mock James M
Chief Financial Officer
|
— | — | 2026-04-02 |